Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02354300 · ClinicalTrials.gov registry record

Transcranial Doppler Ultrasound Monitoring During Flow-Diverter Embolization

A clinical trial, sponsored by University of Florida.

Completed
Registry status
2
Enrollment target

NCT02354300: Completed study, sponsored by University of Florida.

NCT02354300 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02354300 has completed, sponsored by University of Florida.

COMPLETED
Registry status
2 participants
Enrollment target

Study Summary

Flow diverters have been approved since 2012 for the treatment of large, wide neck intracranial aneurysms. These devices have been associated with embolic events which cause blockage in a blood vessel and can result in long term complications. One possible cause of these events is the formation of small emboli during placement of the device.

Primary Outcome

The number of subjects who experience microemboli during device placement.

Interventions

  • DEVICE TCD Ultrasound

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2015-04
Est. Completion 2015-05
University of Florida

1,106 total trials

What the finished NCT02354300 record still lists

NCT02354300 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which TCD Ultrasound is the first listed.

NCT02354300 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02354300 about?

NCT02354300 is a clinical study titled "Transcranial Doppler Ultrasound Monitoring During Flow-Diverter Embolization". Flow diverters have been approved since 2012 for the treatment of large, wide neck intracranial aneurysms. These devices have been associated with embolic events which cause blockage in a blood vessel and can result in long term complications. One possible cause of these events is the formation of s...

What is the current status of trial NCT02354300?

This trial is currently completed. The enrollment target is 2 participants. The study started on 2015-04. Estimated completion is 2015-05.

What interventions are being tested in trial NCT02354300?

The interventions under investigation include: TCD Ultrasound (DEVICE).

Who is sponsoring clinical trial NCT02354300?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02354300, the US trial registry maintained by the National Library of Medicine. NCT02354300 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.